Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo-Reference-Cited by-同舟云学术

Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo

Published:2020 Issue:2 Volume:19 Page:171-179
ISSN:1474-905X
Container-title:Photochemical & Photobiological Sciences
language:en
Short-container-title:Photochem. Photobiol. Sci.

Author:

Malesu Rashi¹²³⁴⁵,Martin Andrew J.⁶⁷⁸,Lyons J. Guy¹²³⁴⁵^ORCID,Scolyer Richard A.⁹¹⁰⁵⁸¹¹^ORCID,Chen Andrew C.¹²³⁴⁵,McKenzie Catriona A.⁹¹⁰⁵⁸¹²,Madore Jason⁹¹⁰⁵⁸¹¹,Halliday Gary M.¹²³⁴⁵,Damian Diona L.¹²³⁴⁵^ORCID

Affiliation:

1. Dermatology

2. Sydney Cancer Centre

3. Bosch Institute

4. The University of Sydney and Royal Prince Alfred Hospital

5. Sydney

6. NHMRC Clinical Trials Centre

7. The University of Sydney

8. Australia

9. Tissue Pathology and Diagnostic Oncology

10. Royal Prince Alfred Hospital and New South Wales Health Pathology

11. Melanoma Institute Australia

12. Sydney Medical School

Abstract

Nicotinamide is chemopreventive against keratinocyte cancers but its effects on melanoma are unknown. Clinically-achievable nicotinamide doses do not enhance melanoma viability, proliferation or invasion and enhance tumour-infiltrating lymphocytes.

Funder

Sydney Medical School Foundation

Australasian College of Dermatologists

National Health and Medical Research Council

University of Sydney

Publisher

Springer Science and Business Media LLC

Subject

Physical and Theoretical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/PP/C9PP00388F

Reference44 articles.